November 13, 2025
The hospital services market is predicted to grow from USD 13.19 trillion in 2026 to USD 28.99 trillion by 203...
Read MoreNovember 01, 2025
The osteoarthritis therapeutics market size is expected to see growth from USD 11.92 billion in 2026 to USD 24...
Read MoreJanuary 21, 2026
The medical device CMO and CDMO market is expected to see growth from USD 52.57 billion in 2026 to USD 110.82 ...
Read MoreDecember 22, 2025
The U.S. behavioral health market is projected to expand from USD 101.84 billion in 2026 to USD 159.35 billion...
Read MoreFebruary 26, 2026
Based on our market research, the AI in personalized nutrition market was valued at USD 1.58 billion in 2025 and reached USD 2.01 billion in 2026, and it is projected to surge to USD 17.59 billion by 2035, expanding at a robust CAGR of 27.25% from 2026 to 2035....
February 26, 2026
Market insights predict, the clinical nutrition industry is expected to grow from USD 78.15 billion in 2025 to USD 170.12 billion by 2035, driven by a CAGR of 8.1%. The market growth is driven by the rising awareness of the importance of nutritional therapies. The significance of nutritional therapy stems from the growing need to combat malnutritio...
February 26, 2026
According to market projections, the global HPV-associated disorders market, valued at USD 21.51 billion in 2025, is anticipated to reach USD 33.88 billion by 2035, growing at a CAGR of 4.65% over the next decade. The HPV HPV-associated disorders Market is growing due to increasing awareness of HPV-related diseases. North America is leading due to ...
February 26, 2026
Market insights predict, the RNA therapeutics and vaccines industry is expected to grow from USD 0.39 billion in 2025 to USD 205.34 billion by 2035, driven by a CAGR of 87%. The RNA therapeutics and vaccines market is growing as it is an innovative and rapidly emerging field at the forefront of medical research and biotechnology. North America is d...
February 26, 2026
According to our projections, the oral GLP-1 sector is expected to grow from USD 6.81 billion in 2025 to USD 137.36 billion by 2035, reflecting a CAGR of 35.05%. the rising prevalence of Type 2 diabetes has driven the growth of the market in the near future. North America led the global market owing to its advanced healthcare infrastructure in the ...
February 26, 2026
Market insights predict the global circadian rhythm sleep disorder industry will increase from USD 2.48 billion in 2025 to USD 4.69 billion by 2035, achieving a CAGR of 6.56%. The circadian rhythm sleep disorder market is growing due to the growing focus on occupational health and efforts taken by employers. North America captured the largest reven...
February 26, 2026
Market insights predict, the U.S. CAR T-cell therapies industry is expected to grow from USD 2.71 billion in 2025 to USD 42.61 billion by 2035, driven by a CAGR of 30.40%. The U.S. CAR T-Cell Therapies Market is growing, as this therapy has high efficacy against blood cancers, robust research and development, and government bodies are accelerating ...
February 26, 2026
According to market projections, the placental stem cell therapy for neurological disorders market is projected to grow from USD 535.65 million in 2025 to USD 2836.93 million by 2035 at a CAGR of 18.14%. The report covers segmentation by cell type, application, therapy type, product & services, and end-user. North America led with 40% revenue i...
February 26, 2026
Market insights predict the global asthma and COPD medicines industry will increase from USD 13.10 billion in 2025 to USD 19.32 billion by 2035, achieving a CAGR of 3.96%. The asthma and COPD medicines market is growing due to the increasing prevalence of these diseases, driven by smoking and pollution, and an increasing and aging worldwide populat...
February 26, 2026
According to market projections, the peptide therapeutics sector is expected to grow from USD 49.17 billion in 2024 to USD 81.5 billion by 2034, reflecting a CAGR of 5.35%. The peptide therapeutics market is growing due to rising demand for personalized medicine. North America is leading the market due to the rising number of clinical trials....